INFLUENCE OF ANTIBODIES AGAINST CTLA-4 AND PD-1 UPON QUANTITIES OF THEIR TARGET RECEPTORS
Inhibitory receptors CTLA-4 and PD-1 (immune checkpoints) play a key role in regulation of immune reactions. They suppress excessive immune response against pathogenic microbes and prevent autoimmune reactions. The immune checkpoints are targets of the modern effective therapy based on human and hum...
Enregistré dans:
Auteurs principaux: | I. O. Chikileva, I. Zh. Shubina, I. V. Samoylenko, A. V. Karaulov, M. V. Kiselevsky |
---|---|
Format: | article |
Langue: | RU |
Publié: |
SPb RAACI
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ca1be543ea6845e3bdecf5e1eee5a835 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
CTLA-4 blockade in the treatment of colorectal cancer with microsatellite instability
par: Diana Russo, et autres
Publié: (2021) -
Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
par: Marc-Oliver Grimm, et autres
Publié: (2021) -
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma
par: Virginia Liberini, et autres
Publié: (2021) -
Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
par: Zoe Apalla, et autres
Publié: (2021) -
Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies
par: Gkiala A, et autres
Publié: (2020)